The role of apoptosis in autoimmune thyroid disorders and thyroid cancer

British Medical Journal

Volumn 322, Issue 7301, 2001, Pages 1525-1527

  Lin, J D ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; FAS ANTIGEN; HLA DR4 ANTIGEN; HLA DR5 ANTIGEN; INTERLEUKIN 1BETA; PROTEIN BCL 2; PROTEIN P53; RETINOIC ACID; THYROTROPIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; AUTOIMMUNE DISEASE; GRAVES DISEASE; HASHIMOTO DISEASE; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; THYROID CANCER; THYROID DISEASE; THYROID MEDULLARY CARCINOMA;

EID: 0035938895     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.322.7301.1525     Document Type: Review

References (30)

1. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis
2. Apoptosis and thyroiditis
3. Hormonal control of programmed cell death/apoptosis
4. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
5. Cell death mediators in autoimmune diabetes - No shortage of suspects
6. Current incidence of thyrotoxicosis and past prevalence of goitre in 12 British towns
7. Prevalence of thyroid cancer in 1894 patients with surgically treated thyroid nodules
8. The causes of autoimmune thyroid disease
9. Trends in thyroid cancer incidence in Sweden 1958-1981, by histopathologic type
10. Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells
11. Analysis of apoptosis in relation to tissue destruction associated with Hashomoto's autoimmune thyroiditis
12. Modulation of Fas-mediated apoptosis of human thyroid epithelial cell by IgG, from patients with Graves' disease (GD) and idiopathic myxedema
13. Chronic autoimmune thyroiditis
14. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
15. Increased serum soluble Fas in patients with Graves' disease
16. Apoptosis during goiter involution - The role of Bcl-2
17. Role of apoptosis of thyrocytes in a rat model of goiter
18. Autoimmune thyroid disease: Further developments in our understanding
19. Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis
20. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis
21. Fas and Fas ligand gene expression in autoimmune thyroiditis in BB/W rats
22. Gene therapy of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for Fas ligand
23. Relation of apoptosis to cancer therapy
24. Apoptosis and proliferation in thyroid carcinoma: Correlation with bcl-2 and p53 protein expression
25. Thyroid carcinoma cells are resistant to Fas-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand
26. Suppression of Fas expression and down-regulation of Fas ligand in highly aggressive human thyroid carcinoma
27. Alltrans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC- 1
28. Interaction of BAG-1 with retinoic acid receptor and its inhibition of retinoic acid-induced apoptosis in cancer cells
29. The MDM2 oncoprotein promotes apoptosis in p53-deficient human medullary thyroid carcinoma cells
30. Signal pathway involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO)